DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lacrisert (Hydroxypropyl Cellulose Ophthalmic) - Published Studies

 
 



Lacrisert Related Published Studies

Well-designed clinical trials related to Lacrisert (Hydroxypropyl Cellulose Ophthalmic)

Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma. [1994]

Well-designed clinical trials possibly related to Lacrisert (Hydroxypropyl Cellulose Ophthalmic)

Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. [2008.07.02]

Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold. [2007.04]

Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms. [1994.07]

Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. [1989.02]

Other research related to Lacrisert (Hydroxypropyl Cellulose Ophthalmic)

Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience. [2011.01]

Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry. [2010.12]

Effect of ethanol on the water permeability of controlled release films composed of ethyl cellulose and hydroxypropyl cellulose. [2010.11]

Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT(R)) therapy with clinical outcomes: tools for predicting response. [2010.10]

Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry. [2010.05]

Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution. [2010.03.15]

Effects of alpha-DT cement with hydroxypropyl cellulose on bone augmentation within a titanium cap in the rabbit calvarium. [2010.03]

Osmotic pumping release from ethyl-hydroxypropyl-cellulose-coated pellets: a new mechanistic model. [2010.02.25]

Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life. [2009.12]

Preparation and characterization of novel semi-interpenetrating polymer network hydrogel microspheres of chitosan and hydroxypropyl cellulose for controlled release of chlorothiazide. [2009.02]

Synthesis of hydroxypropylcellulose-poly(acrylic acid) particles with semi-interpenetrating polymer network structure. [2008.10]

Temperature stability and bioadhesive properties of delta9-tetrahydrocannabinol incorporated hydroxypropylcellulose polymer matrix systems. [2006.01]

Structural characterization of thin hydroxypropylcellulose films. X-ray reflectivity studies. [2004.03.02]

Penetration enhancing effect of menthol on the percutaneous flux of nicardipine hydrochloride through excised rat epidermis from hydroxypropyl cellulose gels. [2002]

Studies on applicability of press-coated tablets using hydroxypropylcellulose (HPC) in the outer shell for timed-release preparations. [2000.08.10]

Evaluation of low-substituted hydroxypropylcelluloses (L-HPCs) as filler-binders for direct compression. [2000.03.20]

Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion with hydroxypropylcellulose. [2000]

Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. [1999.05]

Enhancement of in vivo anti-influenza virus activity of 5,7,4'-trihydroxy-8-methoxyflavone by drug delivery system using hydroxypropyl cellulose. [1997.10]

In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs. [1994.06]

Role of low-substituted hydroxypropylcellulose in dissolution and bioavailability of novel fine granule system for masking bitter taste. [1994.03]

Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose. [1993.11]

Low-substituted hydroxypropylcellulose as a sustained-drug release matrix base or disintegrant depending on its particle size and loading in formulation. [1993.03]

One-shot intravesical instillation of the mucous adhesive anticancer agent hydroxypropylcellulose-doxorubicin for the treatment of superficial bladder carcinoma is sufficient to determine antitumor effects. [1993]

Primary dermal and eye irritability tests of hydrophobically modified hydroxypropyl methylcellulose in rabbits. [1992.02]

Protection of gastric mucosa against ethanol-induced injury by intragastric bolus administration of epidermal growth factor combined with hydroxypropylcellulose. [1992]

Studies on the retention of the mucous-membrane-adhesive anticancer agent hydroxypropylcellulose doxorubicin. [1992]

In vitro evaluation of micronized low-substituted hydroxypropylcellulose as an insoluble swellable matrix for sustained-release tablets. [1991.12]

[Clinical effect on tumor regression and tissue concentration of peplomycin treated with peplomycin emulsion in hydroxypropylcellulosum] [1991.01]

[Instillation of a new anticancer preparation for the treatment of superficial bladder cancer: comparison of clinical efficacy between peplomycin emulsion in hydroxypropylcellulosum and peplomycin in saline solution on tumor reduction] [1990.10.20]

Pharmacological evaluation of hydroxypropylcellulose-ethylcellulose microcapsules containing piretanide. [1990.01]

[A new clinical trial in intravesical chemotherapy with instillation of peplomycin preparation as an emulsion in hydroxypropylcellulosum--preliminary study of patients with bladder tumor] [1989.01]

Performance of a hydroxypropyl cellulose film former in normal and ulcerated oral mucosa. [1988.06]

Other possibly related research studies

Influence of process variable and physicochemical properties on the granulation mechanism of mannitol in a fluid bed top spray granulator. [2005.10]

Controlled release of retinol from silica particles prepared in O/W/O emulsion: the effects of surfactants and polymers. [2005.09.02]

Solvent content and macroviscosity effects on the in vitro transcutaneous delivery and skin distribution of ketoprofen from simple gel formulations. [2005.07]

The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. [2005.06.13]

Preparation and clinical application of indomethacin gel for medical treatment of stomatitis. [2005.05]

Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience. [2004.08]

Herpes simplex and aphthous ulcerations: presentation, diagnosis and management--an update. [2003.11]

Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers. [2004.03.19]

Investigating the coating-dependent release mechanism of a pulsatile capsule using NMR microscopy. [2003.10.30]

Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier. [2003.03]

Enhanced percutaneous permeability of nicardipine hydrochloride by carvone across the rat abdominal skin. [2003.02]

Effect of limonene on the in vitro permeation of nicardipine hydrochloride across the excised rat abdominal skin. [2002.12]

Improvement of periodontal status by green tea catechin using a local delivery system: a clinical pilot study. [2002.12]

The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation. [2002.05]

Evaluation of CC2 as a decontaminant in various hydrophilic and lipophilic formulations against sulphur mustard. [2002.03]

Development of polymer film dosage forms of lidocaine for buccal administration. I. Penetration rate and release rate. [2001.12.13]

Treating the discomfort of oral ulceration resulting from cancer chemotherapy. [1999.04]

Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. [2001.11.09]

Studies on indomethacin inserts prepared by water-soluble polymers. II. The relation between dissolution rate and swelling behaviour. [2001.03]

Use of a moist granulation technique (MGT) to develop controlled-release dosage forms of acetaminophen. [2001.04]

Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. [2000.08.25]

Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations. [2000.07]

Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. [2000.07.20]

Pain relief of oral ulcer by dibucaine-film. [1999.12]

Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. [1999.11]

Galenic development and pharmacokinetic profile of indapamide sustained release 1.5 mg. [1999]

Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation. [1999.01]

Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant. [1998.06]

In vitro performance of floating sustained-release capsule of verapamil. [1998.11]

Simultaneous optimization of wet granulation process involving factor of drug content dependency on granule size. [1998.11]

Isolation and characterization of the viscous, high-molecular-mass microbial carbohydrate fraction from faeces of healthy subjects and patients with Crohn's disease and the consequences for a therapeutic approach. [1998.10]

Oral mucosal adhesive film containing local anesthetics: in vitro and clinical evaluation. [1998.09]

Adherence of two film-forming medications to the oral mucosa. [1997.09]

[Sustained release double-layered progesterone suppository for luteal support therapy] [1997.09]

Subgingival delivery of therapeutic agents in the treatment of periodontal diseases. [1997]

Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. [1996.11]

Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. [1996.11]

Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. [1996.07]

Release of lidocaine from polymer film dosage forms. [1995.10]

Development and evaluation of a buccoadhesive propranolol tablet formulation. [1995.07]

A novel nuclear magnetic resonance (NMR) imaging method for measuring the water front penetration rate in hydrophilic polymer matrix capsule plugs and its role in drug release. [1994.05]

Evaluation of the correlation between in vivo and in vitro release. Effect of the force of contraction and food on drug release. [1994.02]

Development of a novel drug delivery system, time-controlled explosion system (TES). IV. In vivo drug release behavior. [1994]

Clinical evaluation of MGI 209, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy. [1992.12]

Relationship between precorneal retention of viscous eye drops and tear fluid composition. [1992.01]

Nickel contact sensitivity in the guinea pig. An efficient open application test method. [1992]

[The treatment of superficial bladder carcinoma with intravesical HPC-adriamycin and verapamil] [1990.03]

Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin:cellulose derivative combination as a modified-release drug carrier. [1990.03]

[Treatment of radiostomatitis with Salcoat] [1990.01]

Chemical, pharmaceutical and clinical standardization of the TRUE Test caine mix. [1989.07]

Preparation and pharmacokinetic and pharmacodynamic evaluation of hydroxy propyl cellulose-ethyl cellulose microcapsules containing piretanide. [1989.06]

In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex. [2006.08.10]

Influence of cellulose ether mixtures on ibuprofen release: MC25, HPC and HPMC K100M. [2006]

Medicinal carbon tablets for treatment of acetaminophen intoxication: adsorption characteristics of medicinal carbon powder and its tablets. [2006.03]

Bioadhesive tablets for controlled transdermal delivery of drugs. [2005.11]

Formulation of an antispasmodic drug as a topical local anesthetic. [2006.12.01]

Development of mucoadhesive patches for buccal administration of carvedilol. [2007.01]

Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. [2007.06.29]

Preparation of the traditional Chinese medicine compound recipe Shuxiong sustained-release capsules by multiparticulate time-controlled explosion technology. [2007.05]

Stabilization and target delivery of Nattokinase using compression coating. [2007.05]

Experimental study of wet granulation in fluidized bed: impact of the binder properties on the granule morphology. [2007.04.04]

Delivery of itraconazole from extruded HPC films. [2007.07]

Characterization of hot-melt extruded drug delivery systems for onychomycosis. [2007.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017